Lazard上市基礎設施主動型ETF GLIX 深 滬
已收盤 05-08 16:00:00 美东时间
27.0501
-0.005
-0.02%
華盛通- 最 高27.23
- 今 開27.23
- 成交量 1234股
- 最 低 27.0501
- 昨 收 27.055
- 總市值 2637.63万
- 52周最高 30.47
- 市盈率 靜 --
- 換手率 0.13%
- 52周最低 24.7399
- 委 比 0.00%
- 總股本 97.51万
- 歷史最高 30.47
- 量 比 0.11
- 振 幅 0.66%
- 歷史最低 24.7399
- 每 手 1
- 風險率 1.06%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多BioLineRx Announces That The First Patient Has Been Dosed In Its Phase 1/2A Study Of GLIX-1 For The Treatment Of Recurrent And Progressive Glioblastoma And Other High-Grade Gliomas
The GLIX1 program is being conducted under a collaboration between BioLineRx and Hemispherian announced in September 2025. The patient was dosed at NYU Langone Health under the supervision of Dr. Alexandra Miller, Chief
04-28 19:13
BioLineRx Launches First-in-Human Trial of GLIX1 for Glioblastoma
An update from Bioline RX Ltd Sponsored ADR ( ($BLRX) ) is now available. BioLi...
03-26 19:28
BioLineRx Launches First Human Trial For Brain Cancer Drug
BioLineRx Ltd. (NASDAQ:BLRX) (TASE: BLRX), a clinical development stage biopharmaceutical company pursuing life-changing therapies in oncology and rare diseases, today announced the initiation of a first-in-human, Phase
03-26 19:17
